# A Safety and Tolerability Study of CTP-730 in Healthy Volunteers

> **NCT02239081** · PHASE1 · COMPLETED · sponsor: **Concert Pharmaceuticals** · enrollment: 55 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** CTP-730
- **DRUG:** Placebo for CTP-730

## Key facts

- **NCT ID:** NCT02239081
- **Lead sponsor:** Concert Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-09
- **Primary completion:** 2015-01
- **Final completion:** 2015-05
- **Target enrollment:** 55 (ACTUAL)
- **Last updated:** 2015-05-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02239081

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02239081, "A Safety and Tolerability Study of CTP-730 in Healthy Volunteers". Retrieved via AI Analytics 2026-07-06 from https://api.ai-analytics.org/clinical/NCT02239081. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*